Harmony Biosciences
HRMY
$31.69
Share price
4.69%
Change (1 day)
-5.54%
Change (1 year)
Categories
Operating Margin for Harmony Biosciences (HRMY)
Operating Margin as of May 2024 (TTM): 28.24%
According to Harmony Biosciences's latest financial reports and stock price the company's current Operating Margin is 28.24%. At the end of 2022 the company had an Operating Margin of 23.91%.
Operating Margin history for Harmony Biosciences from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 23.91% | 95.11% |
| 2021 | 12.25% | -152.98% |
| 2020 | -23.13% | -99.09% |
| 2019 | -2,535.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -228.75% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -29,813.70% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.